The Effect of a Glaucoma Medication Reminder Cap on Patient Compliance and Intraocular Pressure

Journal of Ocular Pharmacology

Volumn 7, Issue 2, 1991, Pages 117-124

  Chang, John S ^a   Lee, David A ^a   Petursson, Gissur ^b   Spaeth, George ^c   Zimmerman, Thom J ^d   Hoskins, H Dunbar ^e   Mills, Richard ^f   Brown, Reay ^f   Kass, Michael ^f   Lue, John ^f  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c WILLS EYE HOSPITAL   (United States)

^d Department of Ophthalmology ^*  (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPIVEFRINE; LEVOBUNOLOL; PILOCARPINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DRUG LABELING; EPINEPHRINE; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MALE; MIDDLE AGE; OCULAR HYPERTENSION; PATIENT COMPLIANCE; PATIENT SATISFACTION; PILOCARPINE; PROSPECTIVE STUDIES; QUESTIONNAIRES; REMINDER SYSTEMS;

EID: 0025916264     PISSN: 87563320     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.1991.7.117     Document Type: Article

References (12)

1. Blackwell, B. Patient compliance. N. Eng. J. Med.,289:249–252. 1973.
2. Zimmerman, T.J., and Zalta, A. Facilitating patient compliance in glaucoma therapy. Surv. Ophthalmol., 28:252–257, 1983.
3. Vincent, P. Patient's viewpoint of glaucoma therapy. Sight Sav. Rev., 42:213–221, 1972.
4. Roth, H.P., and Caron, H.S. Accuracy of doctors' estimates and patients statements on adherence to drug regimen. Clin. Pharmacol.Ther., 23:361–370, 1978.
5. Bloch, S., Rosenthal, A.R., Friedman, L, and Caldarolla, P. Patient compliance in glaucoma. Br. J. Ophthalmol., 61:531–534, 1977.
6. Blackwell, B. Treatment adherence. Br. J. Psychiatry.129:513–531. 1976.
7. Norell, S.E., and Granstrom, P.A. Self medication with pilocarpine among outpatients in a glaucoma clinic. Br. J. Ophthalmol., 64:137–141, 1980.
8. Gordis, L, Markowitz, M., and Lilienfield, A. The inaccuracy in using interviews to estimate patient reliability in taking medications at home. Med.Care.7:49–54. 1969.
9. Novack, G.D., David, R., Lee, P.F., Freeman, M.I., Duzman, E., and Batoosingh, A.L. Effect of changing medication regimens in glaucoma patients. Ophthalmologica. 96:23–28, 1988.
10. Kass, M.A., Meltzer, D.W., Gordon, M., Cooper, D., and Goldberg, J. Compliance with topical pilocarpine treatment. Am. J. Ophthalmol., 01:515–523, 1986.
11. Kass, M. A., Gordon, M., Morley, R.E., Meltzer, D. W., and Goldberg, J. Compliance with topical timolol treatment. Am. J. Ophthalmol.,103:188–193. 1987.
12. Kass, M.A., Gordon, M., and Meltzer, D.W. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am. J. Ophthalmol.,101:524–530, 1986.